Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
Focus On Billionaire Israel Englander's Top Stock PicksInsider Monkey • Thu, Dec 15, 2011 -
Zweig DiMenna's Top Stock PicksInsider Monkey • Fri, Dec 9, 2011
-
-
-
-
-
-
-
Jim Simons' Defensive Stock PicksInsider Monkey • Fri, Oct 7, 2011
-
20 Biotech Stocks With Strong Corporate GovernanceKapitall • Wed, Oct 5, 2011
-
-
-
5 Highly Shorted Healthcare Stocks Being Sold By Smart MoneyKapitall • Tue, Sep 27, 2011
-
-
-
To learn more about Seeking Alpha Pro, click here.
-
-
Cephalon Stem Cell Deal Catches Analysts Off-GuardEP Vantage • Sun, Dec 12, 2010 -
-
-
-
-
Regulatory Setback for CephalonZacks Investment Research • Wed, Mar 31, 2010 -
Court, FDA Make for a Bad Day at CephalonEP Vantage • Tue, Mar 30, 2010
-
Why It's Time to Sell CephalonNew Low Observer • Wed, Mar 3, 2010
-
Cephalon Beats and Guides HigherZacks Investment Research • Mon, Feb 15, 2010
-
-
Bulls Betting on CephalonoptionMONSTER • Tue, Dec 29, 2009
-
-
-
Cephalon Chugs Along, Despite Fentora, Provigil SetbacksZacks Investment Research • Tue, Jun 16, 2009
-
SL Pharma Wins SFDA Approval for New Drug and a Clinical TrialChinaBio Today • Fri, Aug 29, 2008 -
The Patent System and the High Price of Cephalon's Arsenic TreatmentDerek Lowe • Tue, Sep 18, 2007 -
Cephalon Reduces Debt LevelsH.S. Ayoub • Thu, Jan 11, 2007 -
Cephalon Plunges on Drug RejectionFredric Cohen, M.D. • Sun, Aug 13, 2006
-
-
-
-
-
Focus On Billionaire Israel Englander's Top Stock PicksInsider Monkey • Thu, Dec 15, 2011
-
Zweig DiMenna's Top Stock PicksInsider Monkey • Fri, Dec 9, 2011
-
-
-
-
-
-
-
Jim Simons' Defensive Stock PicksInsider Monkey • Fri, Oct 7, 2011
-
20 Biotech Stocks With Strong Corporate GovernanceKapitall • Wed, Oct 5, 2011
-
-
-
5 Highly Shorted Healthcare Stocks Being Sold By Smart MoneyKapitall • Tue, Sep 27, 2011
-
-
-
-
Cephalon's CEO Discusses Q4 2010 Results - Earnings Call TranscriptThu, Feb 10, 2011 • 2 Comments
-
Cephalon Management Discusses Q3 2010 Results - Earnings Call TranscriptFri, Oct 29, 2010
-
Cephalon Q2 2010 Earnings Call TranscriptThu, Jul 29, 2010
-
Cephalon Q1 2010 Earnings Call TranscriptWed, May 5, 2010
-
Cephalon, Inc. Q4 2009 Earnings Call TranscriptFri, Feb 12, 2010
-
Cephalon Q3 2009 Earnings Call TranscriptTue, Oct 27, 2009
-
Cephalon, Inc. Q2 2009 Earnings Call TranscriptTue, Aug 4, 2009
-
Cephalon Inc. Q1 2009 Earnings Call TranscriptTue, May 5, 2009
-
Cephalon, Inc., Q4 2008 Earnings Call TranscriptFri, Feb 13, 2009 • 1 Comment
-
Cephalon Inc. Q3 2008 Earnings Conference Call TranscriptTue, Oct 28, 2008
-
Cephalon, Inc. Q1 2008 Earnings Call TranscriptFri, May 2, 2008
-
Cephalon, Inc. Q4 2007 Earnings Call TranscriptTue, Feb 12, 2008
-
Cephalon Q3 2007 Earnings Call TranscriptThu, Nov 8, 2007
-
Cephalon Q2 2007 Earnings Call TranscriptTue, Jul 31, 2007
-
Cephalon Q1 2007 Earnings Call TranscriptTue, May 1, 2007
-
Cephalon Q4 2006 Earnings Call TranscriptMon, Feb 12, 2007
-
Cephalon Q3 2006 Earnings Call TranscriptFri, Nov 3, 2006
-
Cephalon Q2 2006 Earnings Conference Call Transcript (CEPH)Fri, Aug 4, 2006
-
Cephalon, Inc. Q1 2006 Earnings Conference Call Transcript (CEPH)Wed, May 3, 2006
-
Cephalon Inc. Q4 2005 Earnings Conference Call Transcript (CEPH)Sat, Feb 18, 2006
-
at MarketWatch.com (Oct 14, 2011)
-
at MarketWatch.com (Oct 12, 2011)
-
at MarketWatch.com (Oct 12, 2011)
-
at MarketWatch.com (Oct 11, 2011)
-
at MarketWatch.com (Oct 10, 2011)
-
at MarketWatch.com (Jul 13, 2011)
-
at MarketWatch.com (Jun 14, 2011)
-
at MarketWatch.com (Jun 10, 2011)
-
at CNBC.com (May 18, 2011)
-
at CNBC.com (May 17, 2011)
-
at MarketWatch.com (May 16, 2011)
-
at MarketWatch.com (May 9, 2011)
-
at MarketWatch.com (May 6, 2011)
-
at MarketWatch.com (May 4, 2011)
-
at MarketWatch.com (May 3, 2011)
-
at CNBC.com (May 2, 2011)
-
at CNBC.com (May 2, 2011)
-
at MarketWatch.com (May 2, 2011)
-
at MarketWatch.com (May 2, 2011)
-
at CNBC.com (May 2, 2011)
CEPH vs. ETF Alternatives
Company Description
Cephalon, Inc. is an international biopharmaceutical company dedicated to the discovery, development and commercialization of innovative products in four core therapeutic areas: central nervous system ("CNS"), pain, oncology and inflammatory disease. In addition to conducting an active... More
